This paper discusses the historical context and criteria for cure in Chagas disease, highlighting the need for long-term clinical trials to evaluate drug efficacy in chronic and cardiac forms.
Answers are grounded in this paper and cite their sources.
Chagas cure criteria lack validation in chronic cardiac forms; leaves open optimal endpoints for long-term efficacy trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gontijo et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: